Free Trial
NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$1.40 +0.05 (+3.70%)
As of 09/26/2025 04:00 PM Eastern

About Gelteq Stock (NASDAQ:GELS)

Advanced

Key Stats

Today's Range
$1.37
$1.43
50-Day Range
$0.96
$1.95
52-Week Range
$0.77
$5.50
Volume
31,671 shs
Average Volume
3.87 million shs
Market Capitalization
$13.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GELS Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $2.32 at the beginning of the year. Since then, GELS shares have decreased by 39.7% and is now trading at $1.40.

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at a price of $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Gelteq's top institutional shareholders include Wedbush Securities Inc. (0.21%).

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/26/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
CIK
1920092
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.79
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$100 thousand
Price / Sales
132.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
1.08

Miscellaneous

Outstanding Shares
9,440,000
Free Float
N/A
Market Cap
$13.22 million
Optionable
N/A
Beta
N/A

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 9/27/2025 by MarketBeat.com Staff
From Our Partners